Showing results (11-20 of 63) with videos related to
Sort By:
Pageof 7
Gene Therapy|April 21, 2001
Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccineM Toda, R L Martuza, S D RabkinMolecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2000
Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factorM Toda, R L Martuza, S D RabkinBrain Research. Molecular Brain Research|December 31, 1996
Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migrationT Yazaki, R L Martuza, S D RabkinGene Therapy|January 14, 2005
Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brainR Liu, R L Martuza, S D RabkinHuman Gene Therapy|October 30, 1998
Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1M Toda, S D Rabkin, R L MartuzaNucleic Acids Research|October 10, 1980
Termination of vitro DNA synthesis at AAF adducts in the DNAP D Moore, S D Rabkin, B S StraussHuman Cell|December 1, 1996
Gene therapy: targeting tumor cells for destructionS D Rabkin, T Mineta, S Miyatake, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 26, 2000
Clinical mutations in the L1 neural cell adhesion molecule affect cell-surface expressionH D Moulding, R L Martuza, S D RabkinBasic Life Sciences|January 1, 1982
In vitro replication of mutagen-damaged DNA: sites of terminationP D Moore, S D Rabkin, B S StraussProceedings of the National Academy of Sciences of the United States of America|March 1, 1983
In vitro bypass of UV-induced lesions by Escherichia coli DNA polymerase I: specificity of nucleotide incorporationS D Rabkin, P D Moore, B S StraussPageof 7